Abdelhalim Motawie
About Candidate
Education
EU2P European Master in Pharmacovigilance & Pharmacoepidemiology. Direct admission to Year 2 with a 50% tuition waiver. Training in pharmacoepidemiology, pharmacovigilance, signal detection, regulatory science and clinical pharmacology.
Six-year integrated Doctor of Pharmacy programme combining pharmaceutical sciences, pharmacology and clinical pharmacy training. Completed practical hospital rotations across oncology, cardiology, intensive care and clinical pharmacy, developing experience in patient care, medication management and multidisciplinary healthcare practice.
Work & Experience
Research Assistant within the Treat-PRYSM project, contributing to pharmacovigilance and pharmacoepidemiological research. Conducted a scoping review evaluating the biological plausibility of drug repurposing signals associated with aneurysmal subarachnoid haemorrhage (aSAH). Performed systematic literature screening, data extraction and evidence synthesis, and collaborated with the research team.
Supported daily community pharmacy operations and dispensing activities alongside PharmD clinical training. Assisted with prescription processing, medication preparation and handling, stock organisation and patient support, gaining practical experience in pharmacy workflow and medication management.
Completed the final year of PharmD clinical training, combining hands-on clinical pharmacy experience with research activities.
• Participated in clinical pharmacy and hospital-based training across oncology, cardiology, intensive care and other clinical settings.
• Developed practical experience in medication management, patient care and multidisciplinary clinical practice.
• Conducted a research case series on levofloxacin-induced musculoskeletal adverse drug reactions, focusing on arthralgia and tendinopathy.
• Applied causality assessment and patient-data analysis and contributed to scientific writing.
